Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database.

Prashanth Ashok KumarDongliang WangDanning HuangAbirami Sivapiragasam

Published in: JCO precision oncology (2024)

Our study showed an overall survival benefit for adjuvant chemotherapy use in patients with ER-positive, N0 premenopausal BC patients, age less than 50 years, with an intermediate RS score, particularly 21-25.

Keyphrases

positive breast cancer
end stage renal disease
postmenopausal women
newly diagnosed
ejection fraction
chronic kidney disease
free survival
peritoneal dialysis
emergency department
estrogen receptor
breast cancer cells
adverse drug
endoplasmic reticulum